KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 156 filers reported holding KURA ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,902,906 | -10.0% | 7,335,845 | +4.4% | 3.62% | -9.1% |
| Q2 2023 | $74,360,916 | -7.5% | 7,028,442 | +6.9% | 3.98% | +17.1% |
| Q1 2023 | $80,391,887 | +1.6% | 6,573,335 | +3.1% | 3.40% | +2.2% |
| Q4 2022 | $79,136,274 | +42.6% | 6,376,815 | +56.9% | 3.32% | +44.2% |
| Q3 2022 | $55,502,000 | -24.6% | 4,063,128 | +1.1% | 2.30% | -17.7% |
| Q2 2022 | $73,632,000 | +17.6% | 4,017,000 | +3.2% | 2.80% | +46.4% |
| Q1 2022 | $62,600,000 | +25.2% | 3,893,019 | +9.0% | 1.91% | +97.5% |
| Q4 2021 | $50,014,000 | +8.5% | 3,572,419 | +45.2% | 0.97% | +24.7% |
| Q3 2021 | $46,080,000 | +33.2% | 2,460,202 | +48.3% | 0.78% | +50.1% |
| Q2 2021 | $34,584,000 | +67.0% | 1,658,706 | +126.5% | 0.52% | +69.0% |
| Q1 2021 | $20,705,000 | +133.5% | 732,415 | +169.8% | 0.31% | +140.9% |
| Q4 2020 | $8,867,000 | +143.2% | 271,500 | +128.2% | 0.13% | +92.4% |
| Q3 2020 | $3,646,000 | – | 119,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |